The Pharmaceutical Base (phase I) in the Qinzhou Port Area is a major project aiming to build a high-level biomedical technology research, development and achievement transformation base for manufacturing, development and research, business demonstrations, business conferences, marketing promotions and international exchanges.

The project is expected to facilitate the biomedical processing trade industrialization of the China-Malaysia Qinzhou Industrial Park and Southwest China. It covers an area of 138.59 mu (9.24 hectares) and has a floor area of 178,000 square meters. The main buildings of phase I have already been completed for enterprises to settle down.

The project’s total investment is estimated at 610 million yuan ($94.04 million) and will attract eligible projects from relevant industries.

The project is expected to have an operation period of 14 years and a business income totaling more than 2.1 billion yuan. The pre-tax internal rate of return, the pre-tax investment payback period and the rate of return on investment are estimated at 13.08 percent, 10.11 years and 13.45 percent respectively.

Cooperation modes:

Joint venture, cooperative operation and attracting projects from relevant industries are all available.

For further details, please visit in person.

General layout of the pharmaceutical base (phase I) in the Qinzhou Port Area [Photo/qzftz.gxzf.gov.cn]

Contact:

Guo Qinghui +86-15007772014